Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 5Breast 2Genitourinary 1

Conditions

Urologic Diseases 1Renal Insufficiency 1Neoplasms 1Kidney Neoplasms 1Kidney Diseases 1Hypothermia 1Carcinoma, Renal Cell 1

Interventions

Docetaxel 409pembrolizumab 331Prednisone 290enzalutamide 285Gemcitabine 274Radiotherapy 270Magnetic Resonance Spectroscopy 269Nivolumab 253Abiraterone Acetate 218Cisplatin 212Leuprolide 195Radiosurgery 192Sunitinib 188Carboplatin 161Androgen Antagonists 156bicalutamide 152Specimen Handling 149Goserelin 149Ipilimumab 131Paclitaxel 126acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 122apalutamide 118Cyclophosphamide 117Bevacizumab 116Sorafenib 114Everolimus 111abiraterone 108cabozantinib 105atezolizumab 105Biopsy 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ice × Genitourinary × Clear all
NCT01529658 2016-10-27

Renal Hypothermia During Partial Nephrectomy

Ottawa Hospital Research Institute

Phase NA Unknown
184 enrolled
Genitourinary

Carcinoma, Renal Cell, Hypothermia, Kidney Diseases, Kidney Neoplasms, Neoplasms, Urologic Diseases, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡